-
1
-
-
0141484615
-
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
-
Kamal, A.; Thao, L.; Sensintaffar, J.; Zhang, L.; Boehm, M.F.; Fritz, L.C.; Burrows, F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425, 407-410.
-
(2003)
Nature
, vol.425
, pp. 407-410
-
-
Kamal, A.1
Thao, L.2
Sensintaffar, J.3
Zhang, L.4
Boehm, M.F.5
Fritz, L.C.6
Burrows, F.J.7
-
2
-
-
0042855994
-
17aag: Low target binding affinity and potent cell activity-Finding an explanation
-
Chiosis, G.; Huezo, H.; Rosen, N.; Mimnaugh, E.; Whitesell, L.; Neckers, L. 17aag: Low target binding affinity and potent cell activity-Finding an explanation. Mol. Cancer Ther. 2003, 2, 123-129.
-
(2003)
Mol. Cancer Ther
, vol.2
, pp. 123-129
-
-
Chiosis, G.1
Huezo, H.2
Rosen, N.3
Mimnaugh, E.4
Whitesell, L.5
Neckers, L.6
-
3
-
-
76349103270
-
Virtual prototyping study shows increased atpase activity of Hsp90 to be the key determinant of cancer phenotype
-
Vali, S.; Pallavi, R.; Kapoor, S.; Tatu, U. Virtual prototyping study shows increased atpase activity of Hsp90 to be the key determinant of cancer phenotype. Syst. Synth. Biol. 2010, 4, 25-33.
-
(2010)
Syst. Synth. Biol
, vol.4
, pp. 25-33
-
-
Vali, S.1
Pallavi, R.2
Kapoor, S.3
Tatu, U.4
-
4
-
-
35348890981
-
Drugging the cancer chaperone Hsp90: Combinatorial therapeutic exploitation of oncogene addiction and tumor stress
-
Workman, P.; Burrows, F.; Neckers, L.; Rosen, N. Drugging the cancer chaperone Hsp90: Combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann. NY Acad. Sci. 2007, 1113, 202-216.
-
(2007)
Ann. NY Acad. Sci
, vol.1113
, pp. 202-216
-
-
Workman, P.1
Burrows, F.2
Neckers, L.3
Rosen, N.4
-
5
-
-
41149111451
-
The Hsp90 molecular chaperone: An open and shut case for treatment
-
Pearl, L.H.; Prodromou, C.; Workman, P. The Hsp90 molecular chaperone: An open and shut case for treatment. Biochem. J. 2008, 410, 439-453.
-
(2008)
Biochem. J
, vol.410
, pp. 439-453
-
-
Pearl, L.H.1
Prodromou, C.2
Workman, P.3
-
6
-
-
70350568650
-
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones
-
Kang, B.H.; Altieri, D.C. Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones. Oncogene 2009, 28, 3681-3688.
-
(2009)
Oncogene
, vol.28
, pp. 3681-3688
-
-
Kang, B.H.1
Altieri, D.C.2
-
7
-
-
74249085361
-
Update on Hsp90 inhibitors in clinical trial
-
Kim, Y.S.; Alarcon, S.V.; Lee, S.; Lee, M.J.; Giaccone, G.; Neckers, L.; Trepel, J.B. Update on Hsp90 inhibitors in clinical trial. Curr. Top. Med. Chem. 2009, 9, 1479-1492.
-
(2009)
Curr. Top. Med. Chem
, vol.9
, pp. 1479-1492
-
-
Kim, Y.S.1
Alarcon, S.V.2
Lee, S.3
Lee, M.J.4
Giaccone, G.5
Neckers, L.6
Trepel, J.B.7
-
8
-
-
77954945333
-
Targeting the dynamic Hsp90 complex in cancer
-
Trepel, J.; Mollapour, M.; Giaccone, G.; Neckers, L. Targeting the dynamic Hsp90 complex in cancer. Nat. Rev. Cancer 2010, 10, 537-549.
-
(2010)
Nat. Rev. Cancer
, vol.10
, pp. 537-549
-
-
Trepel, J.1
Mollapour, M.2
Giaccone, G.3
Neckers, L.4
-
9
-
-
77955348541
-
Hsp90 as a gatekeeper of tumor angiogenesis: Clinical promise and potential pitfalls
-
doi: 10.1155/2010/412985
-
Bohonowych, J.E.; Gopal, U.; Isaacs, J.S. Hsp90 as a gatekeeper of tumor angiogenesis: Clinical promise and potential pitfalls. J. Oncol. 2010, 2010, doi: 10.1155/2010/412985.
-
(2010)
J. Oncol
, pp. 2010
-
-
Bohonowych, J.E.1
Gopal, U.2
Isaacs, J.S.3
-
10
-
-
74249111545
-
Ansamycin inhibitors of Hsp90: Nature's prototype for anti-chaperone therapy
-
Porter, J.R.; Ge, J.; Lee, J.; Normant, E.; West, K. Ansamycin inhibitors of Hsp90: Nature's prototype for anti-chaperone therapy. Curr. Top. Med. Chem. 2009, 9, 1386-1418.
-
(2009)
Curr. Top. Med. Chem
, vol.9
, pp. 1386-1418
-
-
Porter, J.R.1
Ge, J.2
Lee, J.3
Normant, E.4
West, K.5
-
11
-
-
33746377987
-
Inhibitors of the Hsp90 molecular chaperone: Attacking the master regulator in cancer
-
McDonald, E.; Workman, P.; Jones, K. Inhibitors of the Hsp90 molecular chaperone: Attacking the master regulator in cancer. Curr. Top. Med. Chem. 2006, 6, 1091-1107.
-
(2006)
Curr. Top. Med. Chem
, vol.6
, pp. 1091-1107
-
-
McDonald, E.1
Workman, P.2
Jones, K.3
-
12
-
-
33746341544
-
Discovery and development of pyrazole-scaffold Hsp90 inhibitors
-
McDonald, E.; Jones, K.; Brough, P.A.; Drysdale, M.J.; Workman, P. Discovery and development of pyrazole-scaffold Hsp90 inhibitors. Curr. Top. Med. Chem. 2006, 6, 1193-1203.
-
(2006)
Curr. Top. Med. Chem
, vol.6
, pp. 1193-1203
-
-
McDonald, E.1
Jones, K.2
Brough, P.A.3
Drysdale, M.J.4
Workman, P.5
-
13
-
-
38349157746
-
4,5-diarylisoxazole Hsp90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
-
Brough, P.A.; Aherne, W.; Barril, X.; Borgognoni, J.; Boxall, K.; Cansfield, J.E.; Cheung, K.M.; Collins, I.; Davies, N.G.; Drysdale, M.J et al. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer. J. Med. Chem. 2008, 51, 196-218.
-
(2008)
J. Med. Chem
, vol.51
, pp. 196-218
-
-
Brough, P.A.1
Aherne, W.2
Barril, X.3
Borgognoni, J.4
Boxall, K.5
Cansfield, J.E.6
Cheung, K.M.7
Collins, I.8
Davies, N.G.9
Drysdale, M.J.10
-
14
-
-
42349084306
-
Nvp-auy922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
-
Eccles, S.A.; Massey, A.; Raynaud, F.I.; Sharp, S.Y.; Box, G.; Valenti, M.; Patterson, L.; de Haven Brandon, A.; Gowan, S.; Boxall, F et al. Nvp-auy922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res. 2008, 68, 2850-2860.
-
(2008)
Cancer Res
, vol.68
, pp. 2850-2860
-
-
Eccles, S.A.1
Massey, A.2
Raynaud, F.I.3
Sharp, S.Y.4
Box, G.5
Valenti, M.6
Patterson, L.7
de Haven Brandon, A.8
Gowan, S.9
Boxall, F.10
-
15
-
-
51449093764
-
Targeting Hsp90: Small-molecule inhibitors and their clinical development
-
Taldone, T.; Gozman, A.; Maharaj, R.; Chiosis, G. Targeting Hsp90: Small-molecule inhibitors and their clinical development. Curr. Opin. Pharmacol. 2008, 8, 370-374.
-
(2008)
Curr. Opin. Pharmacol
, vol.8
, pp. 370-374
-
-
Taldone, T.1
Gozman, A.2
Maharaj, R.3
Chiosis, G.4
-
16
-
-
80355148497
-
Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise by mutation to the ATP binding pocket of a eukaryotic Hsp90
-
doi: 10.1096/fj.11-188821
-
Millson, S.H.; Chun, C.-S.; Roe, S.M.; Polier, S.; Solovieva, S.; Pearl, L.H.; Sim, T.-S.; Prodromou, C.; Piper, P.W. Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise by mutation to the ATP binding pocket of a eukaryotic Hsp90. FASEB J. 2011, doi: 10.1096/fj.11-188821.
-
(2011)
FASEB J
-
-
Millson, S.H.1
Chun, C.-S.2
Roe, S.M.3
Polier, S.4
Solovieva, S.5
Pearl, L.H.6
Sim, T.-S.7
Prodromou, C.8
Piper, P.W.9
-
17
-
-
65649143827
-
Structural basis of the radicicol resistance displayed by a fungal Hsp90
-
Prodromou, C.; Nuttall, J.M.; Millson, S.H.; Roe, S.M.; Suan, S.T.; Tan, D.; Workman, P.; Pearl, L.H.; Piper, P.W. Structural basis of the radicicol resistance displayed by a fungal Hsp90. ACS Chem. Biol. 2009, 4, 289-297.
-
(2009)
ACS Chem. Biol
, vol.4
, pp. 289-297
-
-
Prodromou, C.1
Nuttall, J.M.2
Millson, S.H.3
Roe, S.M.4
Suan, S.T.5
Tan, D.6
Workman, P.7
Pearl, L.H.8
Piper, P.W.9
-
18
-
-
34548698879
-
A rhizosphere fungus enhances arabidopsis thermotolerance through production of an Hsp90 inhibitor
-
McLellan, C.A.; Turbyville, T.J.; Wijeratne, E.M.; Kerschen, A.; Vierling, E.; Queitsch, C.; Whitesell, L.; Gunatilaka, A.A. A rhizosphere fungus enhances arabidopsis thermotolerance through production of an Hsp90 inhibitor. Plant Physiol. 2007, 145, 174-182.
-
(2007)
Plant Physiol
, vol.145
, pp. 174-182
-
-
McLellan, C.A.1
Turbyville, T.J.2
Wijeratne, E.M.3
Kerschen, A.4
Vierling, E.5
Queitsch, C.6
Whitesell, L.7
Gunatilaka, A.A.8
-
19
-
-
0037359504
-
Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans
-
David, C.L.; Smith, H.E.; Raynes, D.A.; Pulcini, E.J.; Whitesell, L. Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans. Cell Stress Chaperones 2003, 8, 93-104.
-
(2003)
Cell Stress Chaperones
, vol.8
, pp. 93-104
-
-
David, C.L.1
Smith, H.E.2
Raynes, D.A.3
Pulcini, E.J.4
Whitesell, L.5
-
20
-
-
0031005361
-
Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent
-
Stebbins, C.E.; Russo, A.A.; Schneider, C.; Rosen, N.; Hartl, F.U.; Pavletich, N.P. Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell 1997, 89, 239-250.
-
(1997)
Cell
, vol.89
, pp. 239-250
-
-
Stebbins, C.E.1
Russo, A.A.2
Schneider, C.3
Rosen, N.4
Hartl, F.U.5
Pavletich, N.P.6
-
21
-
-
0032959590
-
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin
-
Roe, S.M.; Prodromou, C.; O'Brien, R.; Ladbury, J.E.; Piper, P.W.; Pearl, L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 1999, 42, 260-266.
-
(1999)
J. Med. Chem
, vol.42
, pp. 260-266
-
-
Roe, S.M.1
Prodromou, C.2
O'Brien, R.3
Ladbury, J.E.4
Piper, P.W.5
Pearl, L.H.6
-
22
-
-
0037413714
-
Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90, a property that can be exploited in screens for new Hsp90 chaperone inhibitors
-
Piper, P.W.; Panaretou, B.; Millson, S.H.; Truman, A.; Mollapour, M.; Pearl, L.H.; Prodromou, C. Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90, a property that can be exploited in screens for new Hsp90 chaperone inhibitors. Gene 2003, 302, 165-170.
-
(2003)
Gene
, vol.302
, pp. 165-170
-
-
Piper, P.W.1
Panaretou, B.2
Millson, S.H.3
Truman, A.4
Mollapour, M.5
Pearl, L.H.6
Prodromou, C.7
-
23
-
-
77951938125
-
Mutations that increase both Hsp90 atpase activity in vitro and Hsp90 drug resistance in vivo
-
Zurawska, A.; Urbanski, J.; Matuliene, J.; Baraniak, J.; Klejman, M.P.; Filipek, S.; Matulis, D.; Bieganowski, P. Mutations that increase both Hsp90 atpase activity in vitro and Hsp90 drug resistance in vivo. Biochim. Biophys. Acta 2010, 1803, 575-583.
-
(2010)
Biochim. Biophys. Acta
, vol.1803
, pp. 575-583
-
-
Zurawska, A.1
Urbanski, J.2
Matuliene, J.3
Baraniak, J.4
Klejman, M.P.5
Filipek, S.6
Matulis, D.7
Bieganowski, P.8
-
24
-
-
77950083247
-
A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90alpha/beta
-
Millson, S.H.; Prodromou, C.; Piper, P.W. A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90alpha/beta. Biochem. Pharmcol. 2010, 79, 1581-1588.
-
(2010)
Biochem. Pharmcol
, vol.79
, pp. 1581-1588
-
-
Millson, S.H.1
Prodromou, C.2
Piper, P.W.3
-
25
-
-
33846014703
-
An acetylation site in the middle domain of Hsp90 regulates chaperone function
-
Scroggins, B.T.; Robzyk, K.; Wang, D.; Marcu, M.G.; Tsutsumi, S.; Beebe, K.; Cotter, R.J.; Felts, S.; Toft, D.; Karnitz, L et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 2007, 25, 151-159.
-
(2007)
Mol. Cell
, vol.25
, pp. 151-159
-
-
Scroggins, B.T.1
Robzyk, K.2
Wang, D.3
Marcu, M.G.4
Tsutsumi, S.5
Beebe, K.6
Cotter, R.J.7
Felts, S.8
Toft, D.9
Karnitz, L.10
-
26
-
-
75949112264
-
Swe1/Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function
-
Mollapour, M.; Tsutsumi, S.; Donnelly, A.C.; Beebe, K.; Tokita, M.J.; Lee, M.J.; Lee, S.; Morra, G.; Bourboulia, D.; Scroggins, B.T et al. Swe1/Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol. Cell 2010, 37, 333-343.
-
(2010)
Mol. Cell
, vol.37
, pp. 333-343
-
-
Mollapour, M.1
Tsutsumi, S.2
Donnelly, A.C.3
Beebe, K.4
Tokita, M.J.5
Lee, M.J.6
Lee, S.7
Morra, G.8
Bourboulia, D.9
Scroggins, B.T.10
-
27
-
-
80053425012
-
Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
-
Mollapour, M.; Tsutsumi, S.; Kim, Y.S.; Trepel, J.; Neckers, L. Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity. Oncotarget 2011, 2, 407-417.
-
(2011)
Oncotarget
, vol.2
, pp. 407-417
-
-
Mollapour, M.1
Tsutsumi, S.2
Kim, Y.S.3
Trepel, J.4
Neckers, L.5
-
28
-
-
50249168335
-
Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias
-
Kurokawa, M.; Zhao, C.; Reya, T.; Kornbluth, S. Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. Mol. Cell. Biol. 2008, 28, 5494-5506.
-
(2008)
Mol. Cell. Biol
, vol.28
, pp. 5494-5506
-
-
Kurokawa, M.1
Zhao, C.2
Reya, T.3
Kornbluth, S.4
-
29
-
-
34548104621
-
Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors
-
Lee, S.M.; Bae, J.H.; Kim, M.J.; Lee, H.S.; Lee, M.K.; Chung, B.S.; Kim, D.W.; Kang, C.D.; Kim, S.H. Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors. J. Pharmacol. Exp. Ther. 2007, 322, 1084-1092.
-
(2007)
J. Pharmacol. Exp. Ther
, vol.322
, pp. 1084-1092
-
-
Lee, S.M.1
Bae, J.H.2
Kim, M.J.3
Lee, H.S.4
Lee, M.K.5
Chung, B.S.6
Kim, D.W.7
Kang, C.D.8
Kim, S.H.9
-
30
-
-
0028104545
-
Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines
-
Benchekroun, M.N.; Schneider, E.; Safa, A.R.; Townsend, A.J.; Sinha, B.K. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol. Pharmacol. 1994, 46, 677-684.
-
(1994)
Mol. Pharmacol
, vol.46
, pp. 677-684
-
-
Benchekroun, M.N.1
Schneider, E.2
Safa, A.R.3
Townsend, A.J.4
Sinha, B.K.5
-
31
-
-
74049114496
-
Biib021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance
-
Zhang, H.; Neely, L.; Lundgren, K.; Yang, Y.C.; Lough, R.; Timple, N.; Burrows, F. Biib021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance. Int. J. Cancer 2010, 126, 1226-1234.
-
(2010)
Int. J. Cancer
, vol.126
, pp. 1226-1234
-
-
Zhang, H.1
Neely, L.2
Lundgren, K.3
Yang, Y.C.4
Lough, R.5
Timple, N.6
Burrows, F.7
-
32
-
-
34248166042
-
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues
-
Sharp, S.Y.; Prodromou, C.; Boxall, K.; Powers, M.V.; Holmes, J.L.; Box, G.; Matthews, T.P.; Cheung, K.M.; Kalusa, A.; James, K et al. Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. Mol. Cancer Ther. 2007, 6, 1198-1211.
-
(2007)
Mol. Cancer Ther
, vol.6
, pp. 1198-1211
-
-
Sharp, S.Y.1
Prodromou, C.2
Boxall, K.3
Powers, M.V.4
Holmes, J.L.5
Box, G.6
Matthews, T.P.7
Cheung, K.M.8
Kalusa, A.9
James, K.10
-
33
-
-
0033579175
-
Dt-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
-
Kelland, L.R.; Sharp, S.Y.; Rogers, P.M.; Myers, T.G.; Workman, P. Dt-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90. J. Natl. Cancer Inst. 1999, 91, 1940-1949.
-
(1999)
J. Natl. Cancer Inst
, vol.91
, pp. 1940-1949
-
-
Kelland, L.R.1
Sharp, S.Y.2
Rogers, P.M.3
Myers, T.G.4
Workman, P.5
-
34
-
-
27544446054
-
Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H: Quinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition
-
Guo, W.; Reigan, P.; Siegel, D.; Zirrolli, J.; Gustafson, D.; Ross, D. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H: Quinone oxidoreductase 1: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Cancer Res. 2005, 65, 10006-10015.
-
(2005)
Cancer Res
, vol.65
, pp. 10006-10015
-
-
Guo, W.1
Reigan, P.2
Siegel, D.3
Zirrolli, J.4
Gustafson, D.5
Ross, D.6
-
35
-
-
33748923662
-
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H: Quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins
-
Guo, W.; Reigan, P.; Siegel, D.; Zirrolli, J.; Gustafson, D.; Ross, D. The bioreduction of a series of benzoquinone ansamycins by NAD(P)H: Quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins. Mol. Pharmacol. 2006, 70, 1194-1203.
-
(2006)
Mol. Pharmacol
, vol.70
, pp. 1194-1203
-
-
Guo, W.1
Reigan, P.2
Siegel, D.3
Zirrolli, J.4
Gustafson, D.5
Ross, D.6
-
36
-
-
62449226171
-
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells
-
Gaspar, N.; Sharp, S.Y.; Pacey, S.; Jones, C.; Walton, M.; Vassal, G.; Eccles, S.; Pearson, A.; Workman, P. Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells. Cancer Res. 2009, 69, 1966-1975.
-
(2009)
Cancer Res
, vol.69
, pp. 1966-1975
-
-
Gaspar, N.1
Sharp, S.Y.2
Pacey, S.3
Jones, C.4
Walton, M.5
Vassal, G.6
Eccles, S.7
Pearson, A.8
Workman, P.9
-
37
-
-
73149098932
-
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:Quinone oxidoreductase 1 activity in vivo
-
Douglas, M.; Lim, A.R.; Porter, J.R.; West, K.; Pink, M.M.; Ge, J.; Wylie, A.A.; Tibbits, T.T.; Biggs, K.; Curtis, M et al. The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:Quinone oxidoreductase 1 activity in vivo. Mol. Cancer Ther. 2009, 8, 3369-3378.
-
(2009)
Mol. Cancer Ther
, vol.8
, pp. 3369-3378
-
-
Douglas, M.1
Lim, A.R.2
Porter, J.R.3
West, K.4
Pink, M.M.5
Ge, J.6
Wylie, A.A.7
Tibbits, T.T.8
Biggs, K.9
Curtis, M.10
-
38
-
-
52949096836
-
Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: Relevance for toxicity and mechanism of action
-
Guo, W.; Reigan, P.; Siegel, D.; Ross, D. Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: Relevance for toxicity and mechanism of action. Drug Metab. Dispos. 2008, 36, 2050-2057.
-
(2008)
Drug Metab. Dispos
, vol.36
, pp. 2050-2057
-
-
Guo, W.1
Reigan, P.2
Siegel, D.3
Ross, D.4
-
39
-
-
79952755509
-
Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion
-
Xie, Q.; Wondergem, R.; Shen, Y.; Cavey, G.; Ke, J.; Thompson, R.; Bradley, R.; Daugherty-Holtrop, J.; Xu, Y.; Chen, E et al. Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion. Proc. Natl. Acad. Sci. USA 2011, 108, 4105-4110.
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 4105-4110
-
-
Xie, Q.1
Wondergem, R.2
Shen, Y.3
Cavey, G.4
Ke, J.5
Thompson, R.6
Bradley, R.7
Daugherty-Holtrop, J.8
Xu, Y.9
Chen, E.10
-
40
-
-
52449110026
-
Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors
-
Zhang, M.Q.; Gaisser, S.; Nur, E.A.M.; Sheehan, L.S.; Vousden, W.A.; Gaitatzis, N.; Peck, G.; Coates, N.J.; Moss, S.J.; Radzom, M et al. Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors. J. Med. Chem. 2008, 51, 5494-5497.
-
(2008)
J. Med. Chem
, vol.51
, pp. 5494-5497
-
-
Zhang, M.Q.1
Gaisser, S.2
Nur, E.A.M.3
Sheehan, L.S.4
Vousden, W.A.5
Gaitatzis, N.6
Peck, G.7
Coates, N.J.8
Moss, S.J.9
Radzom, M.10
-
41
-
-
64349108515
-
Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of streptomyces hygroscopicus
-
Menzella, H.G.; Tran, T.T.; Carney, J.R.; Lau-Wee, J.; Galazzo, J.; Reeves, C.D.; Carreras, C.; Mukadam, S.; Eng, S.; Zhong, Z et al. Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of streptomyces hygroscopicus. J. Med. Chem. 2009, 52, 1518-1521.
-
(2009)
J. Med. Chem
, vol.52
, pp. 1518-1521
-
-
Menzella, H.G.1
Tran, T.T.2
Carney, J.R.3
Lau-Wee, J.4
Galazzo, J.5
Reeves, C.D.6
Carreras, C.7
Mukadam, S.8
Eng, S.9
Zhong, Z.10
-
42
-
-
33845301225
-
Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism
-
McCollum, A.K.; Teneyck, C.J.; Sauer, B.M.; Toft, D.O.; Erlichman, C. Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism. Cancer Res. 2006, 66, 10967-10975.
-
(2006)
Cancer Res
, vol.66
, pp. 10967-10975
-
-
McCollum, A.K.1
Teneyck, C.J.2
Sauer, B.M.3
Toft, D.O.4
Erlichman, C.5
-
43
-
-
41649104650
-
Activation of heat shock and antioxidant responses by the natural product celastrol: Transcriptional signatures of a thiol-targeted molecule
-
Trott, A.; West, J.D.; Klaic, L.; Westerheide, S.D.; Silverman, R.B.; Morimoto, R.I.; Morano, K.A. Activation of heat shock and antioxidant responses by the natural product celastrol: Transcriptional signatures of a thiol-targeted molecule. Mol. Biol. Cell 2008, 19, 1104-1112.
-
(2008)
Mol. Biol. Cell
, vol.19
, pp. 1104-1112
-
-
Trott, A.1
West, J.D.2
Klaic, L.3
Westerheide, S.D.4
Silverman, R.B.5
Morimoto, R.I.6
Morano, K.A.7
-
44
-
-
0032555685
-
Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1
-
Zou, J.; Guo, Y.; Guettouche, T.; Smith, D.F.; Voellmy, R. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 1998, 94, 471-480.
-
(1998)
Cell
, vol.94
, pp. 471-480
-
-
Zou, J.1
Guo, Y.2
Guettouche, T.3
Smith, D.F.4
Voellmy, R.5
-
45
-
-
0033890818
-
Induction of a heat shock factor 1-dependent stress response and cytotoxic activity of Hsp90-binding agents
-
Bagatell, R.; Paine-Murrieta, G.D.; Taylor, C.W.; Pulcini, E.J.; Akinaga, S.; Whitesell, L. Induction of a heat shock factor 1-dependent stress response and cytotoxic activity of Hsp90-binding agents. Clin. Cancer Res. 2000, 6, 3312-3318.
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 3312-3318
-
-
Bagatell, R.1
Paine-Murrieta, G.D.2
Taylor, C.W.3
Pulcini, E.J.4
Akinaga, S.5
Whitesell, L.6
-
46
-
-
0035053046
-
Increasing the stress resistance of Saccharomyces cerevisiae, through the overactivation of the heat shock response that results from Hsp90 defects, does not extend replicative life span but can be associated with a slower chronological ageing of nondividing cells
-
Harris, N.; MacLean, M.; Hatzianthis, K.; Panaretou, B.; Piper, P.W. Increasing the stress resistance of Saccharomyces cerevisiae, through the overactivation of the heat shock response that results from Hsp90 defects, does not extend replicative life span but can be associated with a slower chronological ageing of nondividing cells. Mol. Genet. Genomics 2001, 265, 258-263.
-
(2001)
Mol. Genet. Genomics
, vol.265
, pp. 258-263
-
-
Harris, N.1
Maclean, M.2
Hatzianthis, K.3
Panaretou, B.4
Piper, P.W.5
-
47
-
-
74849095191
-
Drugging the heat shock factor 1 pathway: Exploitation of the critical cancer cell dependence on the guardian of the proteome
-
de Billy, E.; Powers, M.V.; Smith, J.R.; Workman, P. Drugging the heat shock factor 1 pathway: Exploitation of the critical cancer cell dependence on the guardian of the proteome. Cell Cycle 2009, 8, 3806-3808.
-
(2009)
Cell Cycle
, vol.8
, pp. 3806-3808
-
-
de Billy, E.1
Powers, M.V.2
Smith, J.R.3
Workman, P.4
-
48
-
-
34548658230
-
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis
-
Dai, C.; Whitesell, L.; Rogers, A.B.; Lindquist, S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007, 130, 1005-1018.
-
(2007)
Cell
, vol.130
, pp. 1005-1018
-
-
Dai, C.1
Whitesell, L.2
Rogers, A.B.3
Lindquist, S.4
-
49
-
-
34248176724
-
Heat shock genes-Integrating cell survival and death
-
Arya, R.; Mallik, M.; Lakhotia, S.C. Heat shock genes-Integrating cell survival and death. J. Biosci. 2007, 32, 595-610.
-
(2007)
J. Biosci
, vol.32
, pp. 595-610
-
-
Arya, R.1
Mallik, M.2
Lakhotia, S.C.3
-
50
-
-
50349096803
-
Dual targeting of Hsc70 and Hsp72 inhibits Hsp90 function and induces tumor-specific apoptosis
-
Powers, M.V.; Clarke, P.A.; Workman, P. Dual targeting of Hsc70 and Hsp72 inhibits Hsp90 function and induces tumor-specific apoptosis. Cancer Cell 2008, 14, 250-262.
-
(2008)
Cancer Cell
, vol.14
, pp. 250-262
-
-
Powers, M.V.1
Clarke, P.A.2
Workman, P.3
-
51
-
-
54749126264
-
P-glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response
-
McCollum, A.K.; TenEyck, C.J.; Stensgard, B.; Morlan, B.W.; Ballman, K.V.; Jenkins, R.B.; Toft, D.O.; Erlichman, C. P-glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response. Cancer Res. 2008, 68, 7419-7427.
-
(2008)
Cancer Res
, vol.68
, pp. 7419-7427
-
-
McCollum, A.K.1
Teneyck, C.J.2
Stensgard, B.3
Morlan, B.W.4
Ballman, K.V.5
Jenkins, R.B.6
Toft, D.O.7
Erlichman, C.8
-
52
-
-
77953576838
-
Targeting Hsp70: The second potentially druggable heat shock protein and molecular chaperone?
-
Powers, M.V.; Jones, K.; Barillari, C.; Westwood, I.; van Montfort, R.L.; Workman, P. Targeting Hsp70: The second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 2010, 9, 1542-1550.
-
(2010)
Cell Cycle
, vol.9
, pp. 1542-1550
-
-
Powers, M.V.1
Jones, K.2
Barillari, C.3
Westwood, I.4
van Montfort, R.L.5
Workman, P.6
-
53
-
-
28544433004
-
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin
-
Guo, F.; Rocha, K.; Bali, P.; Pranpat, M.; Fiskus, W.; Boyapalle, S.; Kumaraswamy, S.; Balasis, M.; Greedy, B.; Armitage, E.S et al. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res. 2005, 65, 10536-10544.
-
(2005)
Cancer Res
, vol.65
, pp. 10536-10544
-
-
Guo, F.1
Rocha, K.2
Bali, P.3
Pranpat, M.4
Fiskus, W.5
Boyapalle, S.6
Kumaraswamy, S.7
Balasis, M.8
Greedy, B.9
Armitage, E.S.10
-
54
-
-
55749084036
-
Cisplatin abrogates the geldanamycin-induced heat shock response
-
McCollum, A.K.; Lukasiewicz, K.B.; Teneyck, C.J.; Lingle, W.L.; Toft, D.O.; Erlichman, C. Cisplatin abrogates the geldanamycin-induced heat shock response. Mol. Cancer Ther. 2008, 7, 3256-3264.
-
(2008)
Mol. Cancer Ther
, vol.7
, pp. 3256-3264
-
-
McCollum, A.K.1
Lukasiewicz, K.B.2
Teneyck, C.J.3
Lingle, W.L.4
Toft, D.O.5
Erlichman, C.6
-
55
-
-
73149102557
-
KU135, a novel novobiocin-derived c-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells
-
Shelton, S.N.; Shawgo, M.E.; Matthews, S.B.; Lu, Y.; Donnelly, A.C.; Szabla, K.; Tanol, M.; Vielhauer, G.A.; Rajewski, R.A.; Matts, R.L et al. KU135, a novel novobiocin-derived c-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells. Mol. Pharmacol. 2009, 76, 1314-1322.
-
(2009)
Mol. Pharmacol
, vol.76
, pp. 1314-1322
-
-
Shelton, S.N.1
Shawgo, M.E.2
Matthews, S.B.3
Lu, Y.4
Donnelly, A.C.5
Szabla, K.6
Tanol, M.7
Vielhauer, G.A.8
Rajewski, R.A.9
Matts, R.L.10
-
56
-
-
61449261930
-
Death by chaperone: Hsp90, Hsp70 or both?
-
Powers, M.V.; Clarke, P.A.; Workman, P. Death by chaperone: Hsp90, Hsp70 or both? Cell Cycle 2009, 8, 518-526.
-
(2009)
Cell Cycle
, vol.8
, pp. 518-526
-
-
Powers, M.V.1
Clarke, P.A.2
Workman, P.3
-
57
-
-
77958019101
-
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma
-
Davenport, E.L.; Zeisig, A.; Aronson, L.I.; Moore, H.E.; Hockley, S.; Gonzalez, D.; Smith, E.M.; Powers, M.V.; Sharp, S.Y.; Workman, P et al. Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma. Leukemia 2010, 24, 1804-1807.
-
(2010)
Leukemia
, vol.24
, pp. 1804-1807
-
-
Davenport, E.L.1
Zeisig, A.2
Aronson, L.I.3
Moore, H.E.4
Hockley, S.5
Gonzalez, D.6
Smith, E.M.7
Powers, M.V.8
Sharp, S.Y.9
Workman, P.10
-
59
-
-
0027937983
-
Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells
-
Lee, Y.J.; Erdos, G.; Hou, Z.Z.; Kim, S.H.; Kim, J.H.; Cho, J.M.; Corry, P.M. Mechanism of quercetin-induced suppression and delay of heat shock gene expression and thermotolerance development in HT-29 cells. Mol. Cell. Biochem. 1994, 137, 141-154.
-
(1994)
Mol. Cell. Biochem
, vol.137
, pp. 141-154
-
-
Lee, Y.J.1
Erdos, G.2
Hou, Z.Z.3
Kim, S.H.4
Kim, J.H.5
Cho, J.M.6
Corry, P.M.7
-
60
-
-
0028951778
-
Quercetin suppresses heat shock response by down regulation of HSF1
-
Nagai, N.; Nakai, A.; Nagata, K. Quercetin suppresses heat shock response by down regulation of HSF1. Biochem. Biophys. Res. Commun. 1995, 208, 1099-1105.
-
(1995)
Biochem. Biophys. Res. Commun
, vol.208
, pp. 1099-1105
-
-
Nagai, N.1
Nakai, A.2
Nagata, K.3
-
61
-
-
0034212740
-
Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells
-
Yokota, S.; Kitahara, M.; Nagata, K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res. 2000, 60, 2942-2948.
-
(2000)
Cancer Res
, vol.60
, pp. 2942-2948
-
-
Yokota, S.1
Kitahara, M.2
Nagata, K.3
-
62
-
-
77953012604
-
Heat shock protein 90 in neurodegenerative diseases
-
Luo, W.; Sun, W.; Taldone, T.; Rodina, A.; Chiosis, G. Heat shock protein 90 in neurodegenerative diseases. Mol. Neurodegener. 2010, 5, 24:1-24:8.
-
(2010)
Mol. Neurodegener
, vol.5
, Issue.24
, pp. 1-24
-
-
Luo, W.1
Sun, W.2
Taldone, T.3
Rodina, A.4
Chiosis, G.5
-
63
-
-
75749136948
-
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease
-
e1000291:1-e1000291:16
-
Neef, D.W.; Turski, M.L.; Thiele, D.J. Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol. 2010, 8, e1000291:1-e1000291:16.
-
(2010)
PLoS Biol
, vol.8
-
-
Neef, D.W.1
Turski, M.L.2
Thiele, D.J.3
-
64
-
-
39349083915
-
Adapting proteostasis for disease intervention
-
Balch, W.E.; Morimoto, R.I.; Dillin, A.; Kelly, J.W. Adapting proteostasis for disease intervention. Science 2008, 319, 916-919.
-
(2008)
Science
, vol.319
, pp. 916-919
-
-
Balch, W.E.1
Morimoto, R.I.2
Dillin, A.3
Kelly, J.W.4
-
65
-
-
44849094781
-
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
-
Morimoto, R.I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 2008, 22, 1427-1438.
-
(2008)
Genes Dev
, vol.22
, pp. 1427-1438
-
-
Morimoto, R.I.1
-
66
-
-
58149229542
-
Enhanced recovery from contraction-induced damage in skeletal muscles of old mice following treatment with the heat shock protein inducer 17-(allylamino)-17-demethoxygeldanamycin
-
Kayani, A.C.; Close, G.L.; Broome, C.S.; Jackson, M.J.; McArdle, A. Enhanced recovery from contraction-induced damage in skeletal muscles of old mice following treatment with the heat shock protein inducer 17-(allylamino)-17-demethoxygeldanamycin. Rejuvenation Res. 2008, 11, 1021-1030.
-
(2008)
Rejuvenation Res
, vol.11
, pp. 1021-1030
-
-
Kayani, A.C.1
Close, G.L.2
Broome, C.S.3
Jackson, M.J.4
McArdle, A.5
-
67
-
-
0032527991
-
Proteasome inhibition leads to the activation of all members of the heat-shock-factor family
-
Kawazoe, Y.; Nakai, A.; Tanabe, M.; Nagata, K. Proteasome inhibition leads to the activation of all members of the heat-shock-factor family. Eur. J. Biochem. FEBS 1998, 255, 356-362.
-
(1998)
Eur. J. Biochem. FEBS
, vol.255
, pp. 356-362
-
-
Kawazoe, Y.1
Nakai, A.2
Tanabe, M.3
Nagata, K.4
-
68
-
-
77954955686
-
Heat shock factors: Integrators of cell stress, development and lifespan
-
Akerfelt, M.; Morimoto, R.I.; Sistonen, L. Heat shock factors: Integrators of cell stress, development and lifespan. Nat. Rev. 2010, 11, 545-555.
-
(2010)
Nat. Rev
, vol.11
, pp. 545-555
-
-
Akerfelt, M.1
Morimoto, R.I.2
Sistonen, L.3
-
69
-
-
77950485584
-
Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the co-chaperone p23
-
Chadli, A.; Felts, S.J.; Wang, Q.; Sullivan, W.P.; Botuyan, M.V.; Fauq, A.; Ramirez-Alvarado, M.; Mer, G. Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the co-chaperone p23. J. Biol. Chem. 2010, 285, 4224-4231.
-
(2010)
J. Biol. Chem
, vol.285
, pp. 4224-4231
-
-
Chadli, A.1
Felts, S.J.2
Wang, Q.3
Sullivan, W.P.4
Botuyan, M.V.5
Fauq, A.6
Ramirez-Alvarado, M.7
Mer, G.8
-
70
-
-
72149125851
-
Characterization of celastrol to inhibit HSP90 and CDC37 interaction
-
Zhang, T.; Li, Y.; Yu, Y.; Zou, P.; Jiang, Y.; Sun, D. Characterization of celastrol to inhibit HSP90 and CDC37 interaction. J. Biol. Chem. 2009, 284, 35381-35389.
-
(2009)
J. Biol. Chem
, vol.284
, pp. 35381-35389
-
-
Zhang, T.1
Li, Y.2
Yu, Y.3
Zou, P.4
Jiang, Y.5
Sun, D.6
-
71
-
-
33947356281
-
Bortezomib-mediated 26s proteasome inhibition causes cell-cycle arrest and induces apoptosis in cd-30+ anaplastic large cell lymphoma
-
Bonvini, P.; Zorzi, E.; Basso, G.; Rosolen, A. Bortezomib-mediated 26s proteasome inhibition causes cell-cycle arrest and induces apoptosis in cd-30+ anaplastic large cell lymphoma. Leukemia 2007, 21, 838-842.
-
(2007)
Leukemia
, vol.21
, pp. 838-842
-
-
Bonvini, P.1
Zorzi, E.2
Basso, G.3
Rosolen, A.4
-
72
-
-
0344393566
-
Sensitivity to Hsp90-targeting drugs can arise with mutation to the hsp90 chaperone, cochaperones and plasma membrane ATP binding cassette transporters of yeast
-
Piper, P.W.; Millson, S.H.; Mollapour, M.; Panaretou, B.; Siligardi, G.; Pearl, L.H.; Prodromou, C. Sensitivity to Hsp90-targeting drugs can arise with mutation to the hsp90 chaperone, cochaperones and plasma membrane ATP binding cassette transporters of yeast. Eur. J. Biochem. 2003, 270, 4689-4695.
-
(2003)
Eur. J. Biochem
, vol.270
, pp. 4689-4695
-
-
Piper, P.W.1
Millson, S.H.2
Mollapour, M.3
Panaretou, B.4
Siligardi, G.5
Pearl, L.H.6
Prodromou, C.7
-
73
-
-
40449089789
-
Silencing of Hsp90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin
-
Holmes, J.L.; Sharp, S.Y.; Hobbs, S.; Workman, P. Silencing of Hsp90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 2008, 68, 1188-1197.
-
(2008)
Cancer Res
, vol.68
, pp. 1188-1197
-
-
Holmes, J.L.1
Sharp, S.Y.2
Hobbs, S.3
Workman, P.4
-
74
-
-
43249105354
-
P23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity
-
Forafonov, F.; Toogun, O.A.; Grad, I.; Suslova, E.; Freeman, B.C.; Picard, D. P23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity. Mol. Cell. Biol. 2008, 28, 3446-3456.
-
(2008)
Mol. Cell. Biol
, vol.28
, pp. 3446-3456
-
-
Forafonov, F.1
Toogun, O.A.2
Grad, I.3
Suslova, E.4
Freeman, B.C.5
Picard, D.6
-
75
-
-
12344291243
-
Hsp90 and Cdc37-A chaperone cancer conspiracy
-
Pearl, L.H. Hsp90 and Cdc37-A chaperone cancer conspiracy. Curr. Opin. Genet. Dev. 2005, 15, 55-61.
-
(2005)
Curr. Opin. Genet. Dev
, vol.15
, pp. 55-61
-
-
Pearl, L.H.1
-
76
-
-
59449107850
-
Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning
-
Smith, J.R.; Workman, P. Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning. Cell Cycle 2009, 8, 362-372.
-
(2009)
Cell Cycle
, vol.8
, pp. 362-372
-
-
Smith, J.R.1
Workman, P.2
-
77
-
-
0034720255
-
Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia
-
Stepanova, L.; Yang, G.; DeMayo, F.; Wheeler, T.M.; Finegold, M.; Thompson, T.C.; Harper, J.W. Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene 2000, 19, 2186-2193.
-
(2000)
Oncogene
, vol.19
, pp. 2186-2193
-
-
Stepanova, L.1
Yang, G.2
Demayo, F.3
Wheeler, T.M.4
Finegold, M.5
Thompson, T.C.6
Harper, J.W.7
-
78
-
-
0034087051
-
The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin d1 in transformation of multiple tissues
-
Stepanova, L.; Finegold, M.; DeMayo, F.; Schmidt, E.V.; Harper, J.W. The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin d1 in transformation of multiple tissues. Mol. Cell. Biol. 2000, 20, 4462-4473.
-
(2000)
Mol. Cell. Biol
, vol.20
, pp. 4462-4473
-
-
Stepanova, L.1
Finegold, M.2
Demayo, F.3
Schmidt, E.V.4
Harper, J.W.5
-
79
-
-
0042635840
-
Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival
-
Schwarze, S.R.; Fu, V.X.; Jarrard, D.F. Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival. Cancer Res. 2003, 63, 4614-4619.
-
(2003)
Cancer Res
, vol.63
, pp. 4614-4619
-
-
Schwarze, S.R.1
Fu, V.X.2
Jarrard, D.F.3
-
80
-
-
0742269688
-
The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37)
-
Roe, S.M.; Ali, M.M.; Meyer, P.; Vaughan, C.K.; Panaretou, B.; Piper, P.W.; Prodromou, C.; Pearl, L.H. The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 2004, 116, 87-98.
-
(2004)
Cell
, vol.116
, pp. 87-98
-
-
Roe, S.M.1
Ali, M.M.2
Meyer, P.3
Vaughan, C.K.4
Panaretou, B.5
Piper, P.W.6
Prodromou, C.7
Pearl, L.H.8
-
81
-
-
33845215386
-
The Hsp90 cochaperone p23 is essential for perinatal survival
-
Grad, I.; McKee, T.A.; Ludwig, S.M.; Hoyle, G.W.; Ruiz, P.; Wurst, W.; Floss, T.; Miller, C.A., III; Picard, D. The Hsp90 cochaperone p23 is essential for perinatal survival. Mol. Cell. Biol. 2006, 26, 8976-8983.
-
(2006)
Mol. Cell. Biol
, vol.26
, pp. 8976-8983
-
-
Grad, I.1
McKee, T.A.2
Ludwig, S.M.3
Hoyle, G.W.4
Ruiz, P.5
Wurst, W.6
Floss, T.7
Miller, C.A.8
Picard, D.9
-
82
-
-
78449294425
-
High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance
-
Simpson, N.E.; Lambert, W.M.; Watkins, R.; Giashuddin, S.; Huang, S.J.; Oxelmark, E.; Arju, R.; Hochman, T.; Goldberg, J.D.; Schneider, R.J et al. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res. 2010, 70, 8446-8456.
-
(2010)
Cancer Res
, vol.70
, pp. 8446-8456
-
-
Simpson, N.E.1
Lambert, W.M.2
Watkins, R.3
Giashuddin, S.4
Huang, S.J.5
Oxelmark, E.6
Arju, R.7
Hochman, T.8
Goldberg, J.D.9
Schneider, R.J.10
-
83
-
-
33645141178
-
Coupling endoplasmic reticulum stress to the cell-death program: A novel Hsp90-independent role for the small chaperone protein p23
-
Rao, R.V.; Niazi, K.; Mollahan, P.; Mao, X.; Crippen, D.; Poksay, K.S.; Chen, S.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell-death program: A novel Hsp90-independent role for the small chaperone protein p23. Cell Death Differ. 2006, 13, 415-425.
-
(2006)
Cell Death Differ
, vol.13
, pp. 415-425
-
-
Rao, R.V.1
Niazi, K.2
Mollahan, P.3
Mao, X.4
Crippen, D.5
Poksay, K.S.6
Chen, S.7
Bredesen, D.E.8
-
84
-
-
80455170832
-
The small chaperone protein p23 and its cleaved product p19 in cellular stress
-
Epub ahead of print
-
Poksay, K.S.; Banwait, S.; Crippen, D.; Mao, X.; Bredesen, D.E.; Rao, R.V. The small chaperone protein p23 and its cleaved product p19 in cellular stress. J. Mol. Neurosci. 2010, [Epub ahead of print].
-
(2010)
J. Mol. Neurosci
-
-
Poksay, K.S.1
Banwait, S.2
Crippen, D.3
Mao, X.4
Bredesen, D.E.5
Rao, R.V.6
-
85
-
-
11144327054
-
Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis
-
Gausdal, G.; Gjertsen, B.T.; Fladmark, K.E.; Demol, H.; Vandekerckhove, J.; Doskeland, S.O. Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis. Leukemia 2004, 18, 1989-1996.
-
(2004)
Leukemia
, vol.18
, pp. 1989-1996
-
-
Gausdal, G.1
Gjertsen, B.T.2
Fladmark, K.E.3
Demol, H.4
Vandekerckhove, J.5
Doskeland, S.O.6
-
86
-
-
10744223839
-
CHIP activates HSF1 and confers protection against apoptosis and cellular stress
-
Dai, Q.; Zhang, C.; Wu, Y.; McDonough, H.; Whaley, R.A.; Godfrey, V.; Li, H.H.; Madamanchi, N.; Xu, W.; Neckers, L et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J. 2003, 22, 5446-5458.
-
(2003)
EMBO J
, vol.22
, pp. 5446-5458
-
-
Dai, Q.1
Zhang, C.2
Wu, Y.3
McDonough, H.4
Whaley, R.A.5
Godfrey, V.6
Li, H.H.7
Madamanchi, N.8
Xu, W.9
Neckers, L.10
-
87
-
-
0035898534
-
The Hsp90 chaperone complex is both a facilitator and a repressor of the dsrna-dependent kinase PKR
-
Donze, O.; Abbas-Terki, T.; Picard, D. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsrna-dependent kinase PKR. EMBO J. 2001, 20, 3771-3780.
-
(2001)
EMBO J
, vol.20
, pp. 3771-3780
-
-
Donze, O.1
Abbas-Terki, T.2
Picard, D.3
-
88
-
-
12144266330
-
Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
-
Citri, A.; Gan, J.; Mosesson, Y.; Vereb, G.; Szollosi, J.; Yarden, Y. Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation. EMBO Rep. 2004, 5, 1165-1170.
-
(2004)
EMBO Rep
, vol.5
, pp. 1165-1170
-
-
Citri, A.1
Gan, J.2
Mosesson, Y.3
Vereb, G.4
Szollosi, J.5
Yarden, Y.6
-
89
-
-
33746628448
-
Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation
-
Koga, F.; Xu, W.; Karpova, T.S.; McNally, J.G.; Baron, R.; Neckers, L. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc. Natl. Acad. Sci. USA 2006, 103, 11318-11322.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 11318-11322
-
-
Koga, F.1
Xu, W.2
Karpova, T.S.3
McNally, J.G.4
Baron, R.5
Neckers, L.6
-
90
-
-
1942533543
-
Aryl hydrocarbon nuclear translocator (arnt) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway
-
Isaacs, J.S.; Jung, Y.J.; Neckers, L. Aryl hydrocarbon nuclear translocator (arnt) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway. J. Biol. Chem. 2004, 279, 16128-16135.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 16128-16135
-
-
Isaacs, J.S.1
Jung, Y.J.2
Neckers, L.3
-
91
-
-
60549083336
-
Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha
-
Kim, W.Y.; Oh, S.H.; Woo, J.K.; Hong, W.K.; Lee, H.Y. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. Cancer Res. 2009, 69, 1624-1632.
-
(2009)
Cancer Res
, vol.69
, pp. 1624-1632
-
-
Kim, W.Y.1
Oh, S.H.2
Woo, J.K.3
Hong, W.K.4
Lee, H.Y.5
-
92
-
-
73949114912
-
Regulation of Hsp90 client proteins by a cullin5-ring e3 ubiquitin ligase
-
Ehrlich, E.S.; Wang, T.; Luo, K.; Xiao, Z.; Niewiadomska, A.M.; Martinez, T.; Xu, W.; Neckers, L.; Yu, X.F. Regulation of Hsp90 client proteins by a cullin5-ring e3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 2009, 106, 20330-20335.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 20330-20335
-
-
Ehrlich, E.S.1
Wang, T.2
Luo, K.3
Xiao, Z.4
Niewiadomska, A.M.5
Martinez, T.6
Xu, W.7
Neckers, L.8
Yu, X.F.9
-
93
-
-
77955606618
-
Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone Hsp90
-
e11772:1-e11772:13
-
Trisciuoglio, D.; Gabellini, C.; Desideri, M.; Ziparo, E.; Zupi, G.; del Bufalo, D. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone Hsp90. PloS One 2010, 5, e11772:1-e11772:13.
-
(2010)
PloS One
, vol.5
-
-
Trisciuoglio, D.1
Gabellini, C.2
Desideri, M.3
Ziparo, E.4
Zupi, G.5
del Bufalo, D.6
-
94
-
-
79956017927
-
Functional inactivation of endogenous MDM2 and CHIP by Hsp90 causes aberrant stabilization of mutant p53 in human cancer cells
-
Li, D.; Marchenko, N.D.; Schulz, R.; Fischer, V.; Velasco-Hernandez, T.; Talos, F.; Moll, U.M. Functional inactivation of endogenous MDM2 and CHIP by Hsp90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol. Cancer Res. 2011, 9, 577-588.
-
(2011)
Mol. Cancer Res
, vol.9
, pp. 577-588
-
-
Li, D.1
Marchenko, N.D.2
Schulz, R.3
Fischer, V.4
Velasco-Hernandez, T.5
Talos, F.6
Moll, U.M.7
-
95
-
-
57649118512
-
Hsp90-mediated assembly of the 26 s proteasome is involved in major histocompatibility complex class 1 antigen processing
-
Yamano, T.; Mizukami, S.; Murata, S.; Chiba, T.; Tanaka, K.; Udono, H. Hsp90-mediated assembly of the 26 s proteasome is involved in major histocompatibility complex class 1 antigen processing. J. Biol. Chem. 2008, 283, 28060-28065.
-
(2008)
J. Biol. Chem
, vol.283
, pp. 28060-28065
-
-
Yamano, T.1
Mizukami, S.2
Murata, S.3
Chiba, T.4
Tanaka, K.5
Udono, H.6
-
96
-
-
31544454764
-
Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death
-
Georgakis, G.V.; Li, Y.; Rassidakis, G.Z.; Martinez-Valdez, H.; Medeiros, L.J.; Younes, A. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Clin. Cancer Res. 2006, 12, 584-590.
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 584-590
-
-
Georgakis, G.V.1
Li, Y.2
Rassidakis, G.Z.3
Martinez-Valdez, H.4
Medeiros, L.J.5
Younes, A.6
-
97
-
-
83555174308
-
Radicicol, an inhibitor of Hsp90, enhances trail-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins
-
doi: 10.1007/s11010-011-0997-9
-
Kim, Y.J.; Lee, S.A.; Myung, S.C.; Kim, W.; Lee, C.S. Radicicol, an inhibitor of Hsp90, enhances trail-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins. Mol. Cell. Biochem. 2011, doi: 10.1007/s11010-011-0997-9.
-
(2011)
Mol. Cell. Biochem
-
-
Kim, Y.J.1
Lee, S.A.2
Myung, S.C.3
Kim, W.4
Lee, C.S.5
-
98
-
-
33846208233
-
STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival
-
Chatterjee, M.; Jain, S.; Stuhmer, T.; Andrulis, M.; Ungethum, U.; Kuban, R.J.; Lorentz, H.; Bommert, K.; Topp, M.; Kramer, D et al. STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival. Blood 2007, 109, 720-728.
-
(2007)
Blood
, vol.109
, pp. 720-728
-
-
Chatterjee, M.1
Jain, S.2
Stuhmer, T.3
Andrulis, M.4
Ungethum, U.5
Kuban, R.J.6
Lorentz, H.7
Bommert, K.8
Topp, M.9
Kramer, D.10
-
99
-
-
0037131187
-
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
-
Basso, A.D.; Solit, D.B.; Chiosis, G.; Giri, B.; Tsichlis, P.; Rosen, N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 2002, 277, 39858-39866.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 39858-39866
-
-
Basso, A.D.1
Solit, D.B.2
Chiosis, G.3
Giri, B.4
Tsichlis, P.5
Rosen, N.6
-
100
-
-
0036187476
-
TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90
-
Chen, G.; Cao, P.; Goeddel, D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 2002, 9, 401-410.
-
(2002)
Mol. Cell
, vol.9
, pp. 401-410
-
-
Chen, G.1
Cao, P.2
Goeddel, D.V.3
-
101
-
-
0030584088
-
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL
-
Zha, J.; Harada, H.; Yang, E.; Jockel, J.; Korsmeyer, S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 1996, 87, 619-628.
-
(1996)
Cell
, vol.87
, pp. 619-628
-
-
Zha, J.1
Harada, H.2
Yang, E.3
Jockel, J.4
Korsmeyer, S.J.5
-
102
-
-
20544446881
-
Hsp90-Akt phosphorylates Ask1 and inhibits Ask1-mediated apoptosis
-
Zhang, R.; Luo, D.; Miao, R.; Bai, L.; Ge, Q.; Sessa, W.C.; Min, W. Hsp90-Akt phosphorylates Ask1 and inhibits Ask1-mediated apoptosis. Oncogene 2005, 24, 3954-3963.
-
(2005)
Oncogene
, vol.24
, pp. 3954-3963
-
-
Zhang, R.1
Luo, D.2
Miao, R.3
Bai, L.4
Ge, Q.5
Sessa, W.C.6
Min, W.7
-
103
-
-
0037432156
-
Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation
-
Haendeler, J.; Hoffmann, J.; Rahman, S.; Zeiher, A.M.; Dimmeler, S. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett. 2003, 536, 180-186.
-
(2003)
FEBS Lett
, vol.536
, pp. 180-186
-
-
Haendeler, J.1
Hoffmann, J.2
Rahman, S.3
Zeiher, A.M.4
Dimmeler, S.5
-
104
-
-
0034664030
-
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90
-
Pandey, P.; Saleh, A.; Nakazawa, A.; Kumar, S.; Srinivasula, S.M.; Kumar, V.; Weichselbaum, R.; Nalin, C.; Alnemri, E.S.; Kufe, D et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000, 19, 4310-4322.
-
(2000)
EMBO J
, vol.19
, pp. 4310-4322
-
-
Pandey, P.1
Saleh, A.2
Nakazawa, A.3
Kumar, S.4
Srinivasula, S.M.5
Kumar, V.6
Weichselbaum, R.7
Nalin, C.8
Alnemri, E.S.9
Kufe, D.10
-
105
-
-
34249717858
-
Regulation of death-associated protein kinase. stabilization by Hsp90 heterocomplexes
-
Zhang, L.; Nephew, K.P.; Gallagher, P.J. Regulation of death-associated protein kinase. stabilization by Hsp90 heterocomplexes. J. Biol. Chem. 2007, 282, 11795-11804.
-
(2007)
J. Biol. Chem
, vol.282
, pp. 11795-11804
-
-
Zhang, L.1
Nephew, K.P.2
Gallagher, P.J.3
-
106
-
-
73649097539
-
Death-associated protein kinase (DAPK) and signal transduction: Additional roles beyond cell death
-
Lin, Y.; Hupp, T.R.; Stevens, C. Death-associated protein kinase (DAPK) and signal transduction: Additional roles beyond cell death. FEBS J. 2009, 277, 48-57.
-
(2009)
FEBS J
, vol.277
, pp. 48-57
-
-
Lin, Y.1
Hupp, T.R.2
Stevens, C.3
-
107
-
-
77956680686
-
Survivin and IAP proteins in cell-death mechanisms
-
Altieri, D.C. Survivin and IAP proteins in cell-death mechanisms. Biochem. J. 2010, 430, 199-205.
-
(2010)
Biochem. J
, vol.430
, pp. 199-205
-
-
Altieri, D.C.1
-
108
-
-
33646542659
-
Interaction of pro-apoptotic protein HGTD-P with heat shock protein 90 is required for induction of mitochondrial apoptotic cascades
-
Kim, J.Y.; Kim, S.M.; Ko, J.H.; Yim, J.H.; Park, J.H.; Park, J.H. Interaction of pro-apoptotic protein HGTD-P with heat shock protein 90 is required for induction of mitochondrial apoptotic cascades. FEBS Lett. 2006, 580, 3270-3275.
-
(2006)
FEBS Lett
, vol.580
, pp. 3270-3275
-
-
Kim, J.Y.1
Kim, S.M.2
Ko, J.H.3
Yim, J.H.4
Park, J.H.5
Park, J.H.6
-
109
-
-
77950820911
-
Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human a549, HONE-1 and HT-29 cancer cells
-
77:1-77:11
-
Cheung, C.H.; Chen, H.H.; Cheng, L.T.; Lyu, K.W.; Kanwar, J.R.; Chang, J.Y. Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human a549, HONE-1 and HT-29 cancer cells. Mol. Cancer 2010, 9, 77:1-77:11.
-
(2010)
Mol. Cancer
, vol.9
-
-
Cheung, C.H.1
Chen, H.H.2
Cheng, L.T.3
Lyu, K.W.4
Kanwar, J.R.5
Chang, J.Y.6
-
110
-
-
0036530301
-
VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of bcl-2 expression and apoptosis inhibition
-
Dias, S.; Shmelkov, S.V.; Lam, G.; Rafii, S. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of bcl-2 expression and apoptosis inhibition. Blood 2002, 99, 2532-2540.
-
(2002)
Blood
, vol.99
, pp. 2532-2540
-
-
Dias, S.1
Shmelkov, S.V.2
Lam, G.3
Rafii, S.4
-
111
-
-
34547137932
-
Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells
-
Peng, C.; Brain, J.; Hu, Y.; Goodrich, A.; Kong, L.; Grayzel, D.; Pak, R.; Read, M.; Li, S. Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells. Blood 2007, 110, 678-685.
-
(2007)
Blood
, vol.110
, pp. 678-685
-
-
Peng, C.1
Brain, J.2
Hu, Y.3
Goodrich, A.4
Kong, L.5
Grayzel, D.6
Pak, R.7
Read, M.8
Li, S.9
-
112
-
-
35348887850
-
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network
-
Kang, B.H.; Plescia, J.; Dohi, T.; Rosa, J.; Doxsey, S.J.; Altieri, D.C. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007, 131, 257-270.
-
(2007)
Cell
, vol.131
, pp. 257-270
-
-
Kang, B.H.1
Plescia, J.2
Dohi, T.3
Rosa, J.4
Doxsey, S.J.5
Altieri, D.C.6
-
113
-
-
67349088746
-
TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells
-
Costantino, E.; Maddalena, F.; Calise, S.; Piscazzi, A.; Tirino, V.; Fersini, A.; Ambrosi, A.; Neri, V.; Esposito, F.; Landriscina, M. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett. 2009, 279, 39-46.
-
(2009)
Cancer Lett
, vol.279
, pp. 39-46
-
-
Costantino, E.1
Maddalena, F.2
Calise, S.3
Piscazzi, A.4
Tirino, V.5
Fersini, A.6
Ambrosi, A.7
Neri, V.8
Esposito, F.9
Landriscina, M.10
-
114
-
-
77955762940
-
Mitochondrial chaperone TRAP1 and the calcium binding protein sorcin interact and protect cells against apoptosis induced by antiblastic agents
-
Landriscina, M.; Laudiero, G.; Maddalena, F.; Amoroso, M.R.; Piscazzi, A.; Cozzolino, F.; Monti, M.; Garbi, C.; Fersini, A.; Pucci, P et al. Mitochondrial chaperone TRAP1 and the calcium binding protein sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res. 2010, 70, 6577-6586.
-
(2010)
Cancer Res
, vol.70
, pp. 6577-6586
-
-
Landriscina, M.1
Laudiero, G.2
Maddalena, F.3
Amoroso, M.R.4
Piscazzi, A.5
Cozzolino, F.6
Monti, M.7
Garbi, C.8
Fersini, A.9
Pucci, P.10
-
115
-
-
59049083922
-
Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression
-
Tariq, M.; Nussbaumer, U.; Chen, Y.; Beisel, C.; Paro, R. Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proc. Natl. Acad. Sci. USA 2009, 106, 1157-1162.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 1157-1162
-
-
Tariq, M.1
Nussbaumer, U.2
Chen, Y.3
Beisel, C.4
Paro, R.5
-
116
-
-
80052440676
-
The novel heat shock protein 90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor (GIST) xenografts carrying heterogeneous KIT mutations
-
Floris, G.; Sciot, R.; Wozniak, A.; van Looy, T.; Wellens, J.; Faa, G.; Normant, E.; Debiec-Rychter, M.; Schoffski, P. The novel heat shock protein 90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor (GIST) xenografts carrying heterogeneous KIT mutations. Clin. Cancer Res. 2011.
-
(2011)
Clin. Cancer Res
-
-
Floris, G.1
Sciot, R.2
Wozniak, A.3
van Looy, T.4
Wellens, J.5
Faa, G.6
Normant, E.7
Debiec-Rychter, M.8
Schoffski, P.9
-
117
-
-
78651304171
-
Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90
-
Meng, Q.; Chen, X.; Sun, L.; Zhao, C.; Sui, G.; Cai, L. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90. Mol. Cell. Biochem. 2011, 348, 165-171.
-
(2011)
Mol. Cell. Biochem
, vol.348
, pp. 165-171
-
-
Meng, Q.1
Chen, X.2
Sun, L.3
Zhao, C.4
Sui, G.5
Cai, L.6
-
118
-
-
39149087719
-
The evolution of fungal drug resistance: Modulating the trajectory from genotype to phenotype
-
Cowen, L.E. The evolution of fungal drug resistance: Modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 2008, 6, 187-198.
-
(2008)
Nat. Rev. Microbiol
, vol.6
, pp. 187-198
-
-
Cowen, L.E.1
-
119
-
-
66449094961
-
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
-
Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R.E.; Timple, N.; Busch, D.J.; Neely, L.; Sensintaffar, J.L.; Yang, Y.C et al. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Mol. Cancer Ther. 2009, 8, 921-929.
-
(2009)
Mol. Cancer Ther
, vol.8
, pp. 921-929
-
-
Lundgren, K.1
Zhang, H.2
Brekken, J.3
Huser, N.4
Powell, R.E.5
Timple, N.6
Busch, D.J.7
Neely, L.8
Sensintaffar, J.L.9
Yang, Y.C.10
|